Article Information
History
- June 19, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Korea University, College of Medicine, Seoul, Republic of Korea
- 2Ajou University, School of Medicine, Suwon, Republic of Korea
- 3Department of pharmacology, Pusan National University, School of Medicine, Yangsan, Republic of Korea
- 4Cheongsan Public Health Center, Wando, Republic of Korea
- 5So Ahn Public Health Center, Wando, Republic of Korea
- 6Gene and Cell Therapy Research Center for Vessel-associated Diseases, School of Medicine, Pusan National University, Yangsan, Republic of Korea
- 7Gangneung Prison Medical Department, Ministry of Justice, Republic of Korea
- ↵†Corresponding authors:
Min Seo Kim, MD, Korea University, College of Medicine, Director of Cheongsan Public Health Center, Ministry of Health and Welfare, Wando, Republic of Korea, Phone: +82-10-8864-9938, Email: minseolike{at}naver.com, Tae-Ho Hwang, DSS, PhD., Department of pharmacology, Pusan National University, School of Medicine, Yangsan, Republic of Korea, Director of Gene and Cell Therapy Research Center for Vessel-associated Diseases, School of Medicine, Pusan National University, Yangsan, Republic of Korea, Phone: +82-10-71579950
↵* These authors contributed equally to this work.
Posted June 19, 2020.
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis of confounder-adjusted 20212 hospitalized patients
